Medical

Myotonic Workshop Examines Clinical Trial Endpoints and Biomarkers

To support myotonic dystrophy drug development efforts, Myotonic held a science workshop in September 2014 at our annual conference. The workshop brought together more than 50 DM researchers and industry representatives from around the world to review where we are in the development of clinical trial endpoint measures for DM.

Dr. Tetsuo Ashizawa's Multi-Disciplinary Approach

Dr. Tetsuo Ashizawa, MD, has focused his career on the search for DM treatments and care for those affected. His multi-disciplinary, patient-centric approach to care moves DM research out of the lab and into his clinic at the University of Florida.

Endocrine Function Over Time in Patients with Myotonic Dystrophy Type 1

Dr. John Vissing and his colleagues at the University of Copenhagen recently tracked a group of 68 adults with myotonic dystrophy type 1 (DM1), measuring their endocrine function change over 8 years.

University of Iowa to Launch Multidisciplinary DM Clinic

A comprehensive multidisciplinary DM clinic is scheduled to launch late 2014 at the University of Iowa Hospital providing easily accessable services for patients.  

The DMCRN

The DMCRN was established a little over three years ago to evaluate potential DM treatments, prepare possible clinical trial sites and conduct important DM research studies.

Stanford University Myotonic Dystrophy Biobank

Stanford University has launched the DM Biobank to provide high-quality DM biological samples to researchers around the world. By participating in the Biobank, DM community members can play an important role in the development of new therapies that may help patients today and for generations to come.

Genetic Testing for Myotonic Dystrophy

Myotonic community members often contact the Foundation with questions about genetic testing. We spoke with Carly Siskind of Stanford's Neuromuscular Team about the pros and cons of testing.

A Conversation with Dr. Richard T. Moxley, III

Dr. Richard Moxley, Director of the Wellstone Muscular Dystrophy Cooperative Research Center at the University of Rochester and a global leader in DM clinical care and research recently talked with MDF about his long and exceptionally distinguished career in neurology.

Myotonic Grant Recipient Develops Tool for Measuring the Impact of Childhood DM on Quality of Life

To support our commitment to DM research, Myotonic awards fellowship grants to postdoctoral researchers as part of our annual Fund-A-Fellow (FAF) program. We recently caught up with one of our current grant recipients, Dr. Nicholas Johnson, Assistant Professor of Neurology at the University of Utah.

Coping with Depression Associated with Having a Chronic Health Condition

Dr. Danielle Sheypuk, a licensed psychologist in New York, NY, was the presenter for our most recent webinar—the last for 2013— titled “Coping with Depression Associated with Having a Chronic Health Condition.”

© Myotonic Dystrophy Foundation. All rights reserved.